Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)

We hypothesized that plasma-based EGFR mutation analysis for NSCLC may be feasible for monitoring treatment response to EGFR TKIs and also predict drug resistance. Clinically relevant mutations including exon 19 deletion (ex19del), L858R and T790M were analyzed using droplet digital PCR (ddPCR) in l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lee, Ji Yun, Qing, Xu, Xiumin, Wei, Yali, Bai, Chi, Sangah, Bak, So Hyeon, Lee, Ho Yun, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Cho, Eun Kyung, Kim, Dong-Wan, Kim, Hye Ryun, Min, Young Joo, Jung, Sin-Ho, Park, Keunchil, Mao, Mao, Ahn, Myung-Ju
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872763/
https://ncbi.nlm.nih.gov/pubmed/26755650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6874
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados